Myeloma University is Here to Help YOU Online educational program serves nurses and patients!

By Diane Moran IMF Senior Vice President,

Business Relationship Management

The IMF’s Nurse Leadership Board (NLB) has created a FREE educational resource to help nurses and other healthcare professionals to gain knowledge about myeloma and to keep up with the rapid changes in myeloma care. “Myeloma care continues to evolve quickly with new drugs and new regimens, and there is so much that nurses need to know,” said Beth Faiman, a founding member of the NLB. “We created Myeloma University to help enhance the ability of nurses to care for their myeloma patients.”

“The IMF continues to provide the most up-to-date and accurate myeloma-related medical information in a user-friendly format so nurses can help patients be partners in their care,” said Yelak Biru, IMF President & CEO and a 27-year myeloma survivor.

Beth added: “The Myeloma University series helps improve nursing care in myeloma by sharing the NLB’s depth of knowledge in an easily accessible format of 5-to-8-minute videos on key myeloma topics, accompanied by downloadable slides and educational resources for nurses, as well as tools for myeloma patients and their care partners.” Myeloma University modules were developed by the NLB’s faculty of oncology nurse experts, who provide care to patients at leading centers that treat myeloma.

Beth explained that although the modules are created with the intent of providing up-to-date information for nurses, patients and caregivers may find them useful due to the patient tools that are included. “It is important for patients to be empowered and informed so they can be active partners in their healthcare decisions.”

“Each module stands on its own, providing information that nurses need to know if they are caring for patients with myeloma,” added NLB member Donna Catamero, who is featured in several modules, including one on CAR T-cell therapy.

Myeloma University modules can be accessed at university.myeloma.org and currently include:

 Renal impairment in multiple myeloma

 Treatments for multiple myeloma – part 1

 Treatments for multiple myeloma – part 2

 How treatments are selected for patients with myeloma

 Treatment of multiple myeloma with monoclonal antibodies

 CAR T-cell therapy in multiple myeloma

 Maintenance and continuous therapy in multiple myeloma

Additional modules are already in production! MT

“I am sincerely humbled and flattered to be the recipient of the prestigious Brian G.M. Durie Outstanding Achievement Award. Dr. Durie has been an inspiration and a mentor, personally to me and to all of us in this field. His dedication to myeloma research and to the patients is unsurpassed, and it’s such an honor to receive this award in his name,” said Dr. Martin.

Dr. Durie applauded Dr. Martin’s exceptional achievements: “As a myeloma researcher in the midst of a stellar career, it is wonderful to be able to celebrate Dr. Martin’s many accomplishments. He is a researcher, a teacher, and a doctor loved by his many patients for his knowledgeable and compassionate care. He is a true model for all young researchers in the field.”

Yelak Biru, IMF President & CEO and a 27-year myeloma survivor, extended his warmest congratulations and appreciation to this year’s award recipients: “The IMF is honored to have Dr. Mateos as this year’s Robert A. Kyle Lifetime Achievement Awardee, and Dr. Martin as this year’s Brian G.M. Durie

Outstanding Achievement Awardee. Dr. Mateos’ pioneering work and groundbreaking discoveries have paved the way for new insights and innovative approaches in myeloma treatment. Her commitment to excellence, resilience, and tireless pursuit of knowledge have made a lasting impact on the myeloma community and beyond. As the first female recipient of this prestigious award, Dr. Mateos has become a role model for aspiring female scientists – proving that gender should never limit one’s potential for success in the pursuit of scientific excellence. We applaud Dr. Mateos’ exceptional achievements and celebrate this historic milestone with great pride.”

“The Brian G.M. Durie Award is a testament to Dr. Martin’s outstanding achievements – serving as an inspiration to the entire myeloma community. Dr. Martin’s relentless pursuit of knowledge, compassionate care for patients, and unwavering dedication to scientific advancement have profoundly impacted countless individuals’ lives.” MT